Rimonabant
CRESCENDO
Sanofi · Phase 3 · Terminated · Enrollment 18695
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Rimonabant | Cardiovascular Disease | n/r | n/r | n/r | n/r |
| Placebo | Cardiovascular Disease | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Rimonabant
Sanofi · Phase 3 · Terminated · Enrollment 18695
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Rimonabant | Cardiovascular Disease | n/r | n/r | n/r | n/r |
| Placebo | Cardiovascular Disease | n/r | n/r | n/r | n/r |